Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CENOBAMATE vs CERITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CENOBAMATE vs CERITINIB: Safety Overview

Metric CENOBAMATE CERITINIB
Total FAERS Reports 5,643 2,796
Deaths Reported 125 786
Death Rate 2.2% 28.1%
Hospitalizations 1,012 804
Average Patient Age 38.2 yrs 55.6 yrs
% Female Patients 56.4% 55.1%
FDA Approval Date Mar 10, 2020 Apr 29, 2014
Manufacturer SK Life Science, Inc. Novartis Pharmaceuticals Corporation
Route ORAL ORAL
Marketing Status Prescription Discontinued